[1]Hiromi Kan,Yuki Kimura,Hideyuki Hyogo,Takayuki Fukuhara,Hatsue Fujino,Noriaki Naeshiro,Yohji Honda,Tomokazu Kawaoka,Masataka Tsuge,Akira Hiramatsu,Michio Imamura,Yoshiiku Kawakami,Hiroshi Aikata,Hidenori Ochi,Koji Arihiro,Kazuaki Chayama.Non‐invasive assessment of liver steatosis in non‐alcoholic fatty liver disease[J].Hepatology research,2014,44(14):E420-E427.

[2]Ding Qingxue,Wang Dexue,Zhang Xiaohui.Research progress of traditional Chinese medicine in treatment of alcoholic fatty liver[J].Public Medical Forum Magazine,2017,21(16).

[3]赵彩彦.Research progress on the pathogenesis of non alcoholic fatty liver disease[J].Hebei Medical Journal,2003,25(12):883-884.

[4]Johnathan Huey Ming Lum,Mark Chang Chuen Cheah,Wei Qiang Leow,Wei Keat Wan,Tony Kiat Hon Lim,Wan Cheng Chow,Jason Pik Eu Chang,George Boon Bee Goh.Clinical profile of non‐alcoholic fatty liver disease in nonobese patients[J].Journal of gastroenterology and hepatology,2021,36(1):257-261.

[5]Hiromasa Ishii,Yoshinori Horie,Kengo Tomita,Yoshiyuki Yamagishi.Recent progress in alcoholic liver diseases][J].The Japanese journal of gastro-enterology,2003,100(10):1187-1197.

[6]M Komatsu,M Goto,H Yagisawa,O Masamune,S Ookubo,T Waga.A female case of alcoholic liver cirrhosis with rapid progress from alcoholic fatty liver[J].The Japanese journal of gastro-enterology,1989,86(9):2240-2245.

[7]Lorenzo A. Orci,Mario Kreutzfeldt,Nicolas Goossens,Laura Rubbia‐Brandt,Florence Slits,Karim Hammad,Vaihere Delaune,Graziano Oldani,Francesco Negro,Sophie Clment,Carmen Gonelle‐Gispert,Lo H. Buhler,Christian Toso,Stphanie Lacotte.Tolerogenic properties of liver macrophages in non‐alcoholic steatohepatitis[J].Liver international,2020,40(3):609-621.

[8]冯志强,沈志祥,谭诗云.Research advances in pathogenesis of alcoholic fatty liver[J].World Chinese Journal of Digestology,2002,10(3):346-348.

[9]Toshihide Shima,Kojiro Seki,Atsushi Umemura,Rie Ogawa,Ryuji Horimoto,Hirohisa Oya,Rei Sendo,Masayuki Mizuno,Takeshi Okanoue.Influence of lifestyle‐related diseases and age on the development and progression of non‐alcoholic fatty liver disease[J].Hepatology research,2015,45(5):548-559.

[10]Hannes Hagstrm,Patrik Nasr,Mattias Ekstedt,Ulf Hammar,Per Stl,Johan Askling,Rolf Hultcrantz,Stergios Kechagias.Cardiovascular risk factors in non‐alcoholic fatty liver disease[J].Liver international,2019,39(1):197-204.

[11]Satya Priya Sharma,Ki Tae Suk,Dong Joon Kim.Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases[J].World journal of gastroenterology : WJG,2021,27(37):6161-6179.

[12]JIANG Yan-ming,SHI Jun-ping.The progress of pharmacotherapy in non- alcoholic fatty liver disease[J].Chinese Journal of Clinical Hepatology,2011,27(9):986-990.

[13]XIAO shixi,WANG Tao.Research progress of circular RNA[J].Lingnan Modern Clinics in Surgery,2017,17(1):122-127.

[14]黄耀彬,李焕敏,李春光.Association of cholecystectomy with non - alcoholic fatty liver[J].Chinese Journal of Clinical Hepatology,2014(7):644-646.

[15]JU Li-zhong,GENG Xiu-ping.Research progress of liver stem cell transplantation in liver diseases[J].Infectious Disease Information,2010,23(4):249-252.

[16]KS Wenk,KC Arrington,A Ehrlich.Psoriasis and non‐alcoholic fatty liver disease[J].Journal of the European Academy of Dermatology and Venereology,2011,25(4):383-391.

[17]Yerian Lisa.Histopathological evaluation of fatty and alcoholic liver diseases[J].Journal of digestive diseases,2011,12(1):17-24.

[18]CHENG Jieyao,MA Hong.Research progress in noninvasive diagnosis of liver fibrosis in patients with chronic liver diseases[J].Chinese Journal of Clinical Hepatology,2014,30(2):178-181.

[19]Jonathan Merola,AnnMarie Liapakis,David C. Mulligan,Peter S. Yoo.Non‐alcoholic fatty liver disease following liver transplantation: a clinical review[J].Clinical transplantation,2015,29(9):728-737.

[20]H J Spech,H Liehr,H Mitschke.Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases[J].Zeitschrift für Gastroenterologie,1983,21(11):651-659.